Dated end-of-day edition
JW Intelligence Report

Tempus AI Inc / TEM

StockLife Sciences Tools & ServicesLife Sciences Tools & Services
JW Rank62.3/ 100
Official close$61.58+2.57 (+4.36%)
Bid$61.52
Ask$61.75
Previous close$59.01
ATR (14)6.88%
RSI (14)53.5
Volume3.16M
Model reference$60.50
Upside scenario$67.50
Risk reference$56.00
Decision summary

TEM Option Market Prices in Bullish Sentiment and Growth Catalysts

BalancedHigh confidence

The TEM option market displays a bullish outlook, reflecting positive sentiment driven by recent news catalysts, strong technical performance, and analyst upgrades. Elevated implied volatility suggests anticipation of significant price movement, potentially fueled by upcoming earnings and the Personalis acquisition.

Wheel contextTEM options offer opportunities for both bullish and bearish traders. The elevated implied volatility provides potential for premium selling strategies, while the bullish sentiment suggests upside potential for long call positions.
Dated supporting context

JW AI outlook

Bullish

Short-term scenario

Cautiously bullish 1-3 week momentum play on news/analyst catalysts and recent strength, but high uncertainty from extreme volatility (beta 3.7), rich valuation, and potential pullback after today's +5% move. Prefer waiting for dip confirmation rather than chasing.

Three-month outlook

Constructive but highly uncertain. Growth trajectory (25%+ revenue, path to positive Adj. EBITDA/cash flow), expanding AI products/FDA clearances, massive dataset build, and Personalis deal (MRD leadership) could support $70-80+ if execution succeeds and AI healthcare tailwinds persist. Risks include acquisition integration/close delays, competition, reimbursement/execution misses, high valuation multiple compression, broader market/tech selloff, and insider selling. High-beta name could easily retrace to $50s or rally further on catalysts; outcomes highly dependent on Q3 earnings (Nov 3) and deal progress. Not suitable for risk-averse investors.


Market sentiment context

Predominantly bullish among retail/traders on X. Strong focus on AI + genomics/clinical data moat, recent funding/FDA/news catalysts, and analyst PT hikes. Posts highlight long-term potential (e.g. $200 by 2027 calls), trading setups (higher lows, flag off 21 EMA, gamma $60 floor/$65 ceiling targeting 70+), and healthcare AI narrative. Some high-engagement technical charts and options flow discussion. Caution notes on high-risk/volatility but overall positive excitement around precision medicine data flywheel.

Observed market data

Price and technical structure

Dated end-of-day indicator set
Trend reference levels11 observations
20D SMA$63.09
50D SMA$55.92
200D SMA$56.20
9D EMA$61.90
21D EMA$61.02
20D MVWAP$64.22
YTD VWAP$55.01
Daily reference VWAP$60.91
Price vs 20D SMA-1.39%
Price vs 50D SMA11.25%
Price vs 200D SMA10.69%
Momentum kinematics10 observations
RSI (7)51.07
RSI (14)53.47
RSI (21)54.14
Stochastic K14.53
Stochastic D14.60
MACD line1.70
MACD histogram2.67
ADX (14)24.99
MACD acceleration-0.37
RSI velocity0.55
Volatility and price boundaries11 observations
ATR (14)-0.07
ATR (14) %6.88%
Bollinger upper$74.37
Bollinger middle$63.09
Bollinger lower$51.81
Bollinger position0.46%
Volatility environmentHigh
20D realized volatility110.49%
Observed range position66.35%
5D true high$65.79
5D true low$57.72
Participation and institutional flow7 observations
Volume3.16M
20D average volume5.43M
Volume vs 20D average0.58x
20D SMA velocity0.32
50D SMA velocity0.00
Institutional flow0.04
ATR velocity-0.07
Available cached indicators

Detailed decision indicators

Dated authorized values
Market overview7 observations
Price$61.58
DateSep 14, 2026
Volume3.16M
Vwap D$60.91
Mvwap 20$64.22
Change2.57
Change Percentage4.36%
Trend structure6 observations
Trend SignalBullish Recovery
Sma 20$63.09
Sma 50$55.92
Sma 200$56.20
Ema 9$61.90
Ema 21$61.02
Momentum structure9 observations
Rsi 751.07
Rsi 1453.47
Rsi 2154.14
Rsi SignalNeutral
Stoch K14.53
Stoch D14.60
Macd Line1.70
Macd SignalBullish
Macd Hist2.67
Volatility structure3 observations
Atr4.28
Atr Pct6.88%
EnvironmentHigh
Option market context3 observations
Current Iv64.68
Iv Rank39.61
Iv Percentile17.93%
Price boundaries8 observations
Bb Upper74.37
Bb Middle63.09
Bb Lower51.81
Bb Pctb0.46
True High$62.81
True Low$57.72
True High 5d$65.79
True Low 5d$57.72
Three-day velocities7 observations
Sma20$0.32
Sma50$0.00
Mvwap20$0.04
Macd-0.37
Rsi0.55
Volume-360,597
Atr-0.07
Risk radar5 observations
Earnings RiskLow
Earnings DateNov 3, 2026
Macro RiskUnknown
Vol RiskHigh
Structure RiskLow
Deterministic scoring

JW Rank factors

Higher scores indicate stronger observed structure
LiquidityTrading capacity and quote quality proxyCoverage 100%
78
Strategy FitGeneric Wheel premium-selling environment fitCoverage 100%
67
Technical TrendPrice trend, momentum and long-term structureCoverage 100%
74
Market Tail RiskMarket-wide volatility and tail-risk regimeCoverage 100%
56
Fundamental QualityBusiness quality and balance-sheet durabilityCoverage 71%
22
Volatility PressureOption premium pressure relative to realized movementCoverage 100%
49

JW Rank is not a buy/sell rating, and coverage measures field availability—not accuracy or certainty.

Options Intelligence

What the closing chain was pricing

TEM Option Market Prices in Bullish Sentiment and Growth Catalysts

The TEM option market displays a bullish outlook, reflecting positive sentiment driven by recent news catalysts, strong technical performance, and analyst upgrades. Elevated implied volatility suggests anticipation of significant price movement, potentially fueled by upcoming earnings and the Personalis acquisition.

Front ATM IV81.49%
Current IV72.04%
IV Rank55.01
IV Percentile51.00%
25Δ skew-2.06
Term slope-8.74
Term structureBackwardation
Quote coverage99%
Median option spread19.85%
Term structure

Implied volatility by expiration

3 observed expirations
81.5%72.8%
ExpirationDTEATM IVState
2026-09-184.0081.49%
2026-09-2511.0073.99%
2026-10-0218.0072.75%
Reference structures

Defined-risk observations

Bull Put Spread Reference

Expiration
Short strike$59.00
Long strike$58.00
Net credit / share$0.25
Credit / width25.00%
$25$-75$57.45$59.55Expiration payoff per standard 100-share contract

Bear Call Spread Reference

Expiration
Short strike$66.00
Long strike$67.00
Net credit / share$0.18
Credit / width17.50%
$18$-82$65.45$67.55Expiration payoff per standard 100-share contract
Evidence used
  • Implied volatility is significantly elevated at 72.04%, indicating high expectations for price swings in the near term.
  • The term structure exhibits backwardation, with shorter-dated options trading at a premium to longer-dated options, suggesting bullish sentiment and potential for upward price movement.
  • Call option demand outpaces put option demand, as evidenced by the positive 25-delta skew, further supporting a bullish bias.
  • Recent analyst upgrades and price target increases contribute to the optimistic market sentiment.
  • The stock's strong technical performance, including a breakout above key moving averages and a potential golden cross, reinforces the bullish outlook.
Risk context
  • High beta (3.72) indicates significant price volatility, posing a risk for investors with lower risk tolerance.
  • The rich valuation multiples (P/S ~7.3x, P/B ~24x) suggest potential for multiple compression if growth expectations are not met.
  • The success of the Personalis acquisition and integration is crucial for long-term growth prospects.
  • Competition in the AI healthcare space could impact market share and profitability.
Strategy intelligence

Structural fit, not a trade instruction

Wheel fit score67.40

TEM options offer opportunities for both bullish and bearish traders. The elevated implied volatility provides potential for premium selling strategies, while the bullish sentiment suggests upside potential for long call positions.

Execution intelligence

Liquidity and quote conditions

Dollar volume$196.33M
Underlying bid/ask spread0.31%
Option quote coverage99%
Median option spread19.85%
Fundamental intelligence

Business quality context

Factor score22.30
Coverage71%

Business quality and balance-sheet durability

Latest strategy observation

TEM Covered Call signal

Sep 11, 2026 12:11 PM EDT

Covered Call | 2026-09-18 | short $60.00 | $2.37 credit | High turnover

Generalized structural observation only; no quantity, order instruction or personalized recommendation is provided.

Company and fundamental profile

Tempus AI Inc at a glance

Dated valuation, quality, growth and shareholder context

Market position and valuation

Market capitalization$11.22B
Beta2.38
52-week range$40.77 – $104.32
52-week return-33.53%
Shares outstanding180.24M

Profitability and financial quality

Return on equity-54.70%
Operating margin-21.42%
Net margin-17.77%
Debt / equity2.52×

Growth and cash generation

Revenue growth (3Y)58.29%
Revenue / share (TTM)7.85
Book value / share2.47

Trading and reference facts

MarketNasdaq Nms Global Market
CountryUs
CurrencyUsd
IPO dateMay 30, 2025
Company website
Methodology, edition and field coverage
EditionOfficial Close
Ready sections3 / 3
Report identityded76e0fccdde0afbf9da352

JW Rank is deterministic and is not a buy/sell rating. Narrative sections explain dated evidence and do not change the score or observed facts. Coverage measures field availability, not accuracy or certainty. This public edition remains fixed.

Continue with the same symbol

Carry TEM from this dated report into your Watchlist.

The report remains a fixed publication. The App and web workspace continue with current cached quotes, alerts, options context and symbol history.

Important disclosures. Generalized market-structure research only. This report does not consider holdings, objectives, risk tolerance or financial circumstances and is not an investment recommendation, transaction instruction, offer, solicitation or return forecast. Market data, model scores and AI explanations may be delayed, incomplete or incorrect. Past, hypothetical, model and settled-signal results do not predict future results. Options are complex and may involve loss of the entire premium, substantial or theoretically unlimited loss, assignment, early exercise, margin, liquidity and execution risk. Before trading standardized options, read the OCC’s Characteristics and Risks of Standardized Options. Terms of Use · Privacy Policy